Spectropath is an imaging technology company based on research from Emory University and Georgia Tech that allows physicians to immediately recognize targeted tissues such as cancer in real time during surgery, therapeutic, or diagnostic procedures. Spectropath is the exclusive licensee of a portfolio of issued and pending patent applications covering its core technology and future pipeline for improved contrast agents.
